University of Cagliari
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
Cocco, Eleonora;
2022-01-01
Abstract
Except for ocrelizumab, treatment options in primary progressive multiple sclerosis (PPMS) are lacking.
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.